Cancer is complex and can be a devastating diagnosis for individuals and their families. Our researchers work to improve cancer control on many levels, from prevention and screening through treatment and survivorship.
Kaiser Permanente Washington Health Research Institute (KPWHRI) has been studying how to provide life-saving breast cancer screening since 1986. In a novel initiative, researchers used a computer-based registry and collaborations with organizations across the U.S. before electronic health records existed and multi-site studies were common. The program ultimately led to a rich portfolio of studies not only on breast cancer, but also on colorectal, blood, cervical, lung, and thyroid cancers.
“Decades later, Kaiser Permanente Washington is just as committed to developing and evaluating innovations in cancer care,” said Karen Wernli, PhD, KPWHRI associate investigator.
The core of KPWHRI cancer research lies in its participation in many collaborative networks and programs. “Collaboration increases the power of Kaiser Permanente studies and helps us learn from different populations and health care settings,” said Senior Investigator Jessica Chubak, PhD. Examples of these networks include:
Breast Cancer Surveillance Consortium (BCSC)
The BCSC identifies strategies that detect aggressive breast cancer early, minimize harms, and reach diverse communities. Results help policymakers and health systems improve breast cancer screening and surveillance outcomes. The Kaiser Permanente Washington Breast Imaging Registry contributes to this national effort and the BCSC Statistical Coordinating Center resides at KPWHRI.
Population-based Research to Optimize the Screening Process (PROSPR)
The PROSPR national consortium conducts research to improve screening for cervical, colorectal, and lung cancers. PROSPR results will help optimize and tailor screening for different subgroups of the population.
Kaiser Permanente Research Bank (KPRB) Cancer Cohort
The KPRB Cancer Cohort is a national resource for understanding genetic, lifestyle, and environmental factors that contribute to cancer etiology and survival. Electronic health record data, stored tissue specimens, detailed treatment data, and the ability to follow patients for recurrence and mortality are accelerating progress toward improved cancer care.
Some of the cancer research group’s current studies include:
Past findings include:
Lee JM, Ichikawa LE, Wernli KJ, Bowles EAJ, Specht JM, Kerlikowske K, Miglioretti DL, Lowry KP, Tosteson ANA, Stout NK, Houssami N, Onega T, Buist DSM. Impact of surveillance mammography intervals less than one year on performance measures in women with a personal history of breast cancer. J Korean Radiol. 2023 Aug;24(8):729-738. doi: 10.3348/kjr.2022.1038. PubMed
Knerr S, Guo B, Wernli KJ, Mittendorf KF, Feigelson HS, Gilmore MJ, Jarvik GP, Kauffman TL, Keast E, Liles EG, Lynch FL, Muessig KR, Okuyama S, Veenstra DL, Zepp JM, Wilfond BS, Devine B, Goddard KAB. Longitudinal adherence to breast cancer surveillance following cancer genetic testing in an integrated health care system. Breast Cancer Res Treat. 2023 Jul 20. doi: 10.1007/s10549-023-07007-w. [Epub ahead of print]. PubMed
Sung H, Hyun N, Ohman RE, Yang EH, Siegel RL, Jemal A. Mediators of Black-White inequities in cardiovascular mortality among survivors of 18 cancers in the USA. Int J Epidemiol. 2023 Jul 20;dyad097. doi: 10.1093/ije/dyad097. Online ahead of print. PubMed
Dalmat RR, Ziebell RA, Kamineni A, Phipps AI, Weiss NS, Breslau ES, Burnett-Hartman AN, Corley DA, Doria-Rose VP, Green BB, Halm EA, Levin TR, Schottinger JE, Chubak J. Risk of colorectal cancer and colorectal cancer mortality beginning one year after a negative fecal occult blood test, among screen-eligible 76-85-year-olds. Cancer Epidemiol Biomarkers Prev. 2023 Jul 14:EPI-23-0265. doi: 10.1158/1055-9965.EPI-23-0265. [Epub ahead of print]. PubMed
Nyante SJ, Abraham L, Aiello Bowles EJ, Lee CI, Kerlikowske K, Miglioretti DL, Sprague BL, Henderson LM. Racial and ethnic variation in diagnostic mammography performance among women reporting a breast lump. Cancer Epidemiol Biomarkers Prev. 2023 Jul 13:EPI-23-0289. doi: 10.1158/1055-9965.EPI-23-0289. [Epub ahead of print]. PubMed
![]() Melissa L. Anderson, MSPrincipal Collaborative Biostatistician |
![]() Erin J. Bowles, MPHManager, Collaborative Science |
![]() David S. Carrell, PhDAssociate Investigator |
![]() Jessica Chubak, PhDSenior Investigator |
![]() Yates Coley, PhDAssociate Biostatistics Investigator |
![]() Andrea J. Cook, PhDSenior Biostatistics Investigator |
![]() Marlaine Figueroa Gray, PhDAssistant Investigator |
![]() Beverly B. Green, MD, MPHSenior Investigator |
![]() Nora Henrikson, PhD, MPHAssociate Investigator |
![]() Laura E. Ichikawa, MSPrincipal Collaborative Biostatistician |
![]() Aruna Kamineni, PhD, MPHAssistant Investigator |
![]() Jennifer B. McClure, PhDDirector, Investigative Science |
![]() Ellen O'Meara, PhDPrincipal Collaborative Scientist |
![]() Lorella Palazzo, PhDCollaborative Scientist |
![]() Gaia Pocobelli, PhDSenior Collaborative Scientist |
![]() Rod L. Walker, MSSenior Collaborative Biostatistician |
![]() Robert D. Wellman, MSSenior Collaborative Biostatistician |
![]() Karen Wernli, PhDSenior Investigator |
![]() Onchee Yu, MSPrincipal Collaborative Biostatistician |
![]() Weiwei Zhu, MSSenior Collaborative Biostatistician |
![]() Yu-Ru Su, PhDAssistant Biostatistics Investigator |
![]() Brian D. Williamson, PhDAssistant Biostatistics Investigator |
![]() Noorie Hyun, PhDAssistant Biostatistics Investigator |
![]() Pamela A. Shaw, PhD, MSSenior Biostatistics Investigator |
![]() Nicole M. Gatto, PhD, MPHPrincipal Collaborative Scientist |
![]() Meagan C. Brown, PhD, MPHCollaborative Scientist |
Wylie Burke, MD, PhD
University of Washington (UW) Department of Medical History and Ethics
Joann G. Elmore, MD, MPH
Harborview Medical Center; UW Department of Epidemiology
Larry Kessler, ScD
UW Department of Health Services
Constance D. Lehman, MD, PhD
Seattle Cancer Care Alliance; UW Department of Radiology
Kathy Leppig, MD
Kaiser Foundation Health Plan of Washington; UW Department of Pathology
Peggy L. Porter, MD
Fred Hutchinson Cancer Research Center (FHCRC); UW Department of Pathology
Emily White, PhD
FHCRC; UW Department of Epidemiology
Rachel Winer, PhD, MPH
Fred Hutchinson/UW Cancer Consortium; UW Department of Epidemiology